Decoy Therapeutics Inc.
Ticker: 1615219
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q2 FY21 | Q2 FY21 | Q1 FY21 | Q1 FY21 | Q3 FY20 |
|---|---|---|---|---|---|---|
| INCOME | ||||||
| Revenue | 0.23-59.6% | 0.57+0.0% | 0.57-55.1% | 1.27+0.0% | 1.27-8.0% | 1.38 |
| Total Income | 0.23-59.6% | 0.57+0.0% | 0.57-55.1% | 1.27+0.0% | 1.27-8.0% | 1.38 |
| EXPENSES | ||||||
| Expenditure | 2.86-22.5% | 3.69+0.0% | 3.69+20.2% | 3.07+0.0% | 3.07-2.2% | 3.14 |
| PROFIT | ||||||
| Net Profit | -2.37+22.8% | -3.07+0.0% | -3.07-65.9% | -1.85+0.0% | -1.85-7.6% | -1.72 |
| KEY METRICS | ||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -4.46-6271.4% | -0.07+0.0% | -0.07-16.7% | -0.06 | — | -0.10 |
Corporate Events
Board MeetingDCOY
202614Sep
Board Meeting
Decoy Therapeutics Inc. will hold a special meeting of stock…
SEC Filing ↗ Board MeetingDCOY
202614Jul
Board Meeting
2026 Annual Meeting of Stockholders to elect three Class II …
SEC Filing ↗